| BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq – WAFD) |
Globe Newswire |
10/05 |
15:01 |
| The Atlas Hotel Debuts Head Of The Charles Partnership and a Calendar Of Can't-Miss Events For Boston's Fall Season |
Globe Newswire |
10/05 |
15:01 |
| Deadline Alert: Flotek Industries, Inc. (FTK) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit |
Globe Newswire |
10/05 |
15:00 |
| Telos Secures $13.5 Million Contract to Continue Support of Air Force Intelligence Community Cyber Operations |
Globe Newswire |
10/05 |
15:00 |
| Deadline Alert: Hyliion Holdings Corp. (HYLN) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit |
Globe Newswire |
10/05 |
14:55 |
| Deadline Alert: Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit |
Globe Newswire |
10/05 |
14:50 |
| Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma |
Globe Newswire |
10/05 |
14:49 |
| Deadline Alert: DICK’s Sporting Goods, Inc. (DKS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit |
Globe Newswire |
10/05 |
14:45 |
| Deadline Alert: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit |
Globe Newswire |
10/05 |
14:40 |
| Deadline Alert: Lincoln Educational Services Corporation (LINC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit |
Globe Newswire |
10/05 |
14:35 |
| Deadline Alert: Doximity, Inc. (DOCS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit |
Globe Newswire |
10/05 |
14:30 |
| A gut punch in Ohio: Nearly 1,400 laid off at truck factory just days before Trump rally |
AP Online |
10/05 |
14:29 |
| Deadline Alert: Better Home & Finance Holding Company (BETR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit |
Globe Newswire |
10/05 |
14:25 |
| Peapack Private Appoints Ana Parra as Senior Managing Director, Group Director |
Globe Newswire |
10/05 |
14:15 |
| BadCreditMD Launches Comprehensive Website to Empower Consumers with Bad Credit |
Globe Newswire |
10/05 |
14:01 |
| Bronstein, Gewirtz & Grossman LLC Urges Qfin Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/05 |
14:00 |
| Bronstein, Gewirtz & Grossman LLC Urges Flotek Industries, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/05 |
14:00 |
| Bronstein, Gewirtz & Grossman LLC Urges Tigo Energy, Inc. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/05 |
14:00 |
| Bronstein, Gewirtz & Grossman LLC Urges Taboola.com Ltd. Investors to Act: Class Action Filed Alleging Investor Harm |
Globe Newswire |
10/05 |
14:00 |
| Lula seeks shake-up and Flávio Bolsonaro reaches for more support ahead of Brazil's election runoff |
AP Online |
10/05 |
13:58 |
| BolenBliss.com Tops 10,000 Vendor Placements for Multicultural Weddings |
Globe Newswire |
10/05 |
13:47 |
| Discovery Announces Receipt of Key Environmental and Land Use Permits for Cordero Project |
Globe Newswire |
10/05 |
13:15 |
| DOCS INVESTOR NOTICE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - November 16, 2026 Deadline |
Globe Newswire |
10/05 |
13:05 |
| Norsk Hydro: Update on Alunorte gas supply situation |
Globe Newswire |
10/05 |
13:00 |
| Type 2 Diabetes Market to Grow Significantly During the Forecast Period (2026–2036), with Rising Prevalence and Increasing Uptake of Next-Generation Therapies | DelveInsight |
Globe Newswire |
10/05 |
13:00 |
